{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:17Z","timestamp":1786119137167,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/rlu.0b013e31815ef825","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:31:41Z","timestamp":1236216701000},"page":"94-96","source":"Crossref","is-referenced-by-count":17,"title":["Anaphylaxis After Administration of Ibritumomab Tiuxetan for Follicular Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"33","author":[{"given":"Rachel","family":"Jankowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V96.4.1259","article-title":"Radioimmunotherapy with iodine 131I tositomomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience.","volume":"96","author":"Kaminski","year":"2000","journal-title":"Blood"},{"key":"R2-2-20210204","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.2003.08.043","article-title":"Safety of Yttrium-90 Ibritumomab Tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma.","volume":"21","author":"Witzig","year":"2003","journal-title":"J Clin Oncol"},{"key":"R3-2-20210204","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2005.01.009","article-title":"Symposium on the definition and management of anaphylaxis: summary report.","volume":"115","author":"Sampson","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R4-2-20210204","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00262-002-0350-y","article-title":"Human antiglobulin response to foreign antibodies: therapeutic benefit?","volume":"52","author":"DeNardo","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00262-006-0148-4","article-title":"Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.","volume":"55","author":"Azinovic","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1200\/JCO.2005.01.0892","article-title":"Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab.","volume":"23","author":"Kaminski","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-2-20210204","first-page":"406a","article-title":"A phase I trial of two-sequential doses of Zevalin radioimmunotherapy for relapsed low-grade B-cell non-Hodgkin's lymphoma.","volume":"102","author":"Witzig","year":"2003","journal-title":"Blood"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","article-title":"131I-tsitumomab therapy as initial treatment for follicular lymphoma.","volume":"352","author":"Kaminski","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-2-20210204","first-page":"4013s","article-title":"Characterization of human IgG antimouse antibody in patients with B-cell malignancies.","volume":"9","author":"DeNardo","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R10-2-20210204","first-page":"15","article-title":"Kuby Immunology. 4th ed.","author":"Goldsby","year":"2000"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-200802000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:41Z","timestamp":1786038641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-200802000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31815ef825","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}